Phase
Startup
LEAD BIOLOGICS
Developing future targeted immunotherapies in cancer
Lead Biologics identify and explore novel targets for immunotherapies in cancer, based on academic excellence and expertise in recombinant antibody technology to provide first-in-class treatment options.
We collaborate with pharma companies and other stakeholders at an early stage to expedite the development of new antibody-based therapeutics to patients in critical need for new treatment options.
Anki Malmborg Hager has extensive experience from starting life science companies spun-out from Lund University. Anki has served as the CEO of SenzaGen AB, PainDrainer AB, Cantargia AB, XImmune AB and Diaprost AB. She has also been the Investment Director at LU Bioscience AB and the VP for Business Development at Alligator Bioscience AB Today she is the CEO at Lead Biologics International AB, advisor for start-up companies and board member in SenzaGen AB, NanoEcho AB, Avena Partners AB, and Hager Consulting AB.
Did you know?
Immunotherapy has revolutionized cancer treatment, but only 15-60%, dependent on type of cancer, of the patients respond.
New technologies for next-gen antibody therapeutics
Single Molecule Nanowire Biosensors for Diagnostics
Medicines for acute systemic inflammatory diseases
Cancer immunotherapies based in cell reprogramming
Introducing the fungal based industrial revolution
Automated microscopy image acquisition and analysis
Fighting iron deficiency
Implants of magnesium alloys
Developing future targeted immunotherapies in cancer
Digital service for patients
Ultrasound analysis for stroke risk assessment
Medical device that reduces pain during vein operation
Cloud-based solutions for genomics data
A reusable, user-friendly, and sustainable pregnancy test
Digital assistive device for post-surgical rehabilitation
Develops the first effective treatment for hypothyroidism
Builds gene therapy viral vectors
Early detection of pancreatic cancer
Bio-based vegan coating for fruits and vegetables
Equipment that improves the function of cultivated cells
Medtech solution for preventing pressure ulcers
Effective treatments for brain tumors
A new suturing choice for abdominal wall closure
Converting waste flows into valuable raw materials
Innovative systemic anti-inflammatory treatments
Safer medical needles for prostate biopsy
